clinical trial · NCT06346340
A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy
Dry EyeMiebo
brief summary
A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/ Keratometry and Postoperative Refractive Accuracy
started
Apr 30, 2024
primary completion
Feb 24, 2025
completion
Feb 24, 2025
last updated
Jul 6, 2026
detailed description
The primary objective is to determine the effect of preoperative Miebo treatment on the accuracy of preoperative biometry/keratometry and predicted refraction in subjects with dry eye disease (DED) who are already scheduled for cataract surgery.
official title
A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/ Keratometry and Postoperative Refractive Accuracy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol